Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.5300
-0.0154 (-2.82%)
Sep 5, 2025, 2:52 PM EDT
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $1.46 million as of September 5, 2025. Its market cap has decreased by -84.64% in one year.
Market Cap
1.46M
Enterprise Value
2.04M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.53
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 1.46M, a decrease of -98.88%. That is a compound annual growth rate of -46.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.42M | -45.92% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | 46.34M | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 393.37M |
| American Oncology Network | 361.55M |